WATERTOWN, Mass. (AP) _ Enanta Pharmaceuticals Inc. (ENTA) on Monday reported a loss of $26.3 million in its fiscal fourth quarter.
On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of $1.27.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.37 per share.
The biotechnology company posted revenue of $20.3 million in the period, which missed Street forecasts. Four analysts surveyed by Zacks expected $22.5 million.
For the year, the company reported that its loss widened to $121.8 million, or $5.91 per share. Revenue was reported as $86.2 million.